Clinical trial
Chronic Subdural Hematoma Treated With Numen SILK Coiling of Middle Meningeal Artery
NCT07197840 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chronic Subdural Hematoma Treated With Numen SILK Coiling of Middle Meningeal Artery
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 20, 2025
- Completion date
- March 1, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic subdural hematoma